Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer-Reference-Cited by-同舟云学术

Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer

Published:2017-04-27 Issue:9 Volume:58 Page:1442-1449
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kelly James M.,Amor-Coarasa Alejandro,Nikolopoulou Anastasia,Wüstemann Till,Barelli Peter,Kim Dohyun,Williams Clarence,Zheng Xiwei,Bi Cong,Hu Bao,Warren J. David,Hage David S.,DiMagno Stephen G.,Babich John W.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference51 articles.

1. Patchwork

2. Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

3. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617

4. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy

5. Systemic Radioligand Therapy with 177 Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-04

2. Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands;Pharmaceuticals;2024-02-16

3. Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection;Theranostics;2024

4. Albumin-seeking dyes with adjustable assemblies in situ enable programmable imaging windows and targeting tumor imaging;Theranostics;2024

5. ¹⁷⁷Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer;Molecular Pharmaceutics;2023-12-28